Omkar Speciality Chemicals Limited has informed the Exchange about General Updates
Awaiting price reaction for this filing.
Omkar Speciality Chemicals Limited has been admitted into Corporate Insolvency Resolution Process (CIRP) since December 2022. The company has now scheduled a Monitoring Committee meeting on May 27, 2026 to consider unaudited financial statements for three quarters (Q1 to Q3 of FY25), constitution of Audit and Stakeholder Relationship Committees, appointment of an Independent Director, CEO, Statutory and Secretarial Auditors, opening of ICICI Bank account, and discussion on CIRP costs and PBG refund. This indicates the insolvency resolution process is ongoing with regular monitoring and governance updates.
The company remains under insolvency proceedings, which is highly negative for shareholders as the stock may remain suspended or face significant delisting risk depending on the resolution outcome.